These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 9927632)
1. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating. Moorhouse AJ; Jacques P; Barry PH; Schofield PR Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632 [TBL] [Abstract][Full Text] [Related]
2. A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists. Castaldo P; Stefanoni P; Miceli F; Coppola G; Del Giudice EM; Bellini G; Pascotto A; Trudell JR; Harrison NL; Annunziato L; Taglialatela M J Biol Chem; 2004 Jun; 279(24):25598-604. PubMed ID: 15066993 [TBL] [Abstract][Full Text] [Related]
3. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways. Lynch JW; Jacques P; Pierce KD; Schofield PR J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943 [TBL] [Abstract][Full Text] [Related]
4. Properties of human glycine receptors containing the hyperekplexia mutation alpha1(K276E), expressed in Xenopus oocytes. Lewis TM; Sivilotti LG; Colquhoun D; Gardiner RM; Schoepfer R; Rees M J Physiol; 1998 Feb; 507 ( Pt 1)(Pt 1):25-40. PubMed ID: 9490812 [TBL] [Abstract][Full Text] [Related]
5. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. Shan Q; Haddrill JL; Lynch JW J Biol Chem; 2001 Apr; 276(16):12556-64. PubMed ID: 11278873 [TBL] [Abstract][Full Text] [Related]
6. Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols. Borghese CM; Blednov YA; Quan Y; Iyer SV; Xiong W; Mihic SJ; Zhang L; Lovinger DM; Trudell JR; Homanics GE; Harris RA J Pharmacol Exp Ther; 2012 Feb; 340(2):304-16. PubMed ID: 22037201 [TBL] [Abstract][Full Text] [Related]
7. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR J Biol Chem; 1994 Jul; 269(29):18739-42. PubMed ID: 7518444 [TBL] [Abstract][Full Text] [Related]
8. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors. Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097 [TBL] [Abstract][Full Text] [Related]
9. Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation. Wilkins ME; Caley A; Gielen MC; Harvey RJ; Smart TG J Physiol; 2016 Jul; 594(13):3589-607. PubMed ID: 27028707 [TBL] [Abstract][Full Text] [Related]
10. Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists. Rajendra S; Lynch JW; Pierce KD; French CR; Barry PH; Schofield PR Neuron; 1995 Jan; 14(1):169-75. PubMed ID: 7826634 [TBL] [Abstract][Full Text] [Related]
11. Single-channel study of the spasmodic mutation alpha1A52S in recombinant rat glycine receptors. Plested AJ; Groot-Kormelink PJ; Colquhoun D; Sivilotti LG J Physiol; 2007 May; 581(Pt 1):51-73. PubMed ID: 17331994 [TBL] [Abstract][Full Text] [Related]
12. Maximum likelihood fitting of single channel NMDA activity with a mechanism composed of independent dimers of subunits. Schorge S; Elenes S; Colquhoun D J Physiol; 2005 Dec; 569(Pt 2):395-418. PubMed ID: 16223763 [TBL] [Abstract][Full Text] [Related]